Impact of a non-medical switch from tocilizumab to upadacitinib in a cohort of patients with rheumatoid arthritis in routine clinical practice

被引：0
|
作者：
White, Douglas [1 ]
Poppelwell, David [2 ]
机构：
[1] Te Whatu Ora Waikato, Waikato Hosp, Rheumatol Clin, Hamilton, New Zealand
[2] AbbVie Ltd, Med Affairs, Auckland, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1581期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 78
页数：5
相关论文
共 50 条
  • [21] REMISSION AND QUALITY OF LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB IN REAL CLINICAL PRACTICE
    Amirdzhanova, V. N.
    Polishchuk, E. Y.
    Karateev, A. E.
    Filatova, E. S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S286 - S286
  • [22] Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?
    Amirdzhanova, V. N.
    Karateev, A. E.
    Pogozheva, E. Yu.
    Filatova, E. S.
    Samigullina, R. R.
    Mazurov, V. I.
    Anoshenkova, O. N.
    Lapkina, N. A.
    Baranov, A. A.
    Grineva, T. Yu.
    Lila, A. M.
    Nasonov, E. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 511 (01) : 180 - 186
  • [23] Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?
    V. N. Amirdzhanova
    A. E. Karateev
    E. Yu. Pogozheva
    E. S. Filatova
    R. R. Samigullina
    V. I. Mazurov
    O. N. Anoshenkova
    N. A. Lapkina
    A. A. Baranov
    T. Yu. Grineva
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 511 : 180 - 186
  • [24] Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice
    Backhaus, Marina
    Kaufmann, Joerg
    Richter, Constanze
    Wassenberg, Siegfried
    Roske, Anne-Eve
    Hellmann, Peter
    Gaubitz, Markus
    CLINICAL RHEUMATOLOGY, 2015, 34 (04) : 673 - 681
  • [25] Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
    Kaufmann, Joerg
    Feist, Eugen
    Roske, Anne-Eve
    Schmidt, Wolfgang A.
    CLINICAL RHEUMATOLOGY, 2013, 32 (09) : 1347 - 1355
  • [26] Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
    Jörg Kaufmann
    Eugen Feist
    Anne-Eve Roske
    Wolfgang A. Schmidt
    Clinical Rheumatology, 2013, 32 : 1347 - 1355
  • [27] Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice
    Marina Backhaus
    Jörg Kaufmann
    Constanze Richter
    Siegfried Wassenberg
    Anne-Eve Roske
    Peter Hellmann
    Markus Gaubitz
    Clinical Rheumatology, 2015, 34 : 673 - 681
  • [28] What Matters to Patients with Rheumatoid Arthritis When Facing Medical or Non-Medical Treatment Decisions?
    Cornelissen, Lisa Emily
    van der Mark, Elise J.
    Pennings, Patricia
    Maat, Bertha
    Foekens, Theo
    Willemsen-de Mey, Gerardine
    Voogdt-Pruis, Helene R.
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 1827 - 1841
  • [29] IMPACT OF ULTRASOUND IN TREATMENT DECISION OF RHEUMATOID ARTHRITIS ASSESSED IN ROUTINE CLINICAL PRACTICE
    Sifuentes-Cantu, C.
    Saldarriaga-Rivera, L.
    Contreras-Yanez, I.
    Gutierrez, M.
    Pascual-Ramos, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 630 - 630
  • [30] Impact of Ultrasound in Treatment Decision of Rheumatoid Arthritis Assessed in Routine Clinical Practice
    Sifuentes-Cantu, Cesar
    Saldarriaga-Rivera, Lina
    Cecilia Lozada, Ana
    Contreras-Yanez, Irazu
    Gutierrez, Marwin
    Pascual-Ramos, Virginia
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345